Thus although our study falls short of achieving a level of significance needed to identify NCK2 de novo as a glaucoma gene and this polymorphism showed deviation from Hardy–Weinberg equilibrium (p = 0.030 in Stage One), our data do support the prior finding of significant allele frequency differences between NTG cases and normal controls in the Japanese population [16]. This evidence concerns the gene NCK2 and glaucoma.